# Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-chemotherapy-with-or-without-anthracyclines-in-the-presence-of-dual/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mette S. van Ramshorst,Anna van der Voort,Erik van Werkhoven,Ingrid A.M. Mandjes,Inge Kemper,Vincent O. Dezentjé,Irma M. Oving,Aafke H. Honkoop,Lidwine W. Tick,Agnès J. van de Wouw,Caroline M.P.W. Mandigers,Laurence J. van Warmerdam,Jelle Wesseling,Marie-Jeanne TFD Vrancken Peeters,Sabine C. Linn,Gabe S. Sonke |
| Citations | 455 |
| DOI | 10.1016/s1470-2045(18)30570-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pure.eur.nl/ws/files/203950996/Neoadjuvant_chemotherapy_with_or_without_anthracyclines_in_the_presence_of_dual_HER2_blockade_for_HER2-positive_breast_cancer_TRAIN-2_.pdf |
| OpenAlex ID | https://openalex.org/W2899659781 |
| PMID | 30413379 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Jelle Wesseling](https://scholariq.org/researchers/jelle-wesseling/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.